This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Related letter  • Similar articles in JAMA  Topic Collections  • Aging/ Geriatrics  • Men's Health  • Men's Health, Other  • Statistics and Research Methods  • Drug Therapy  • Drug Therapy, Other  • Alert me on articles by topic  Social Bookmarking   What's this?

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In Reply: Drs Page and Matsumoto have concerns about the interpretation and context for some of the results of our trial. Regarding the study population, we aimed to conduct a study in a group of men for whom there is no absolute indication for testosterone treatment, but rather a "gray zone" where some might advocate use of testosterone as a preventive agent for chronic diseases of late life. That was the reason we chose the 50th percentile of the population distribution as the cutoff for inclusion. There is a gradual decline of testosterone levels with aging, and although not all men in our study were hypogonadal, they certainly had lower testosterone concentrations than men aged 30 years. Epidemiological observational studies show that the decline of testosterone is associated with a number of signs and symptoms of aging over the entire range of testosterone, including concentrations that are not clinically defined . . . [Full Text of this Article]

Marielle H. Emmelot-Vonk, MD
m.h.emmelotvonk@umcutrecht.nl

Harald J. J. Verhaar, MD, PhD; Yvonne T. van der Schouw, PhD
University Medical Center Utrecht
Utrecht, the Netherlands

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED LETTER

Effects of Testosterone Therapy in Older Men
Stephanie Page and Alvin M. Matsumoto
JAMA. 2008;299(16):1900.
EXTRACT | FULL TEXT